NIH Policy on Dissemination of NIH-Funded Clinical Trial Information
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_policy
|
| gptkbp:appliesTo |
all NIH-funded clinical trials, regardless of phase or type
NIH-funded clinical trials |
| gptkbp:complianceMonitoredBy |
gptkb:NIH
|
| gptkbp:documentType |
policy notice
|
| gptkbp:goal |
improve access to clinical trial information
increase transparency of clinical trial results |
| https://www.w3.org/2000/01/rdf-schema#label |
NIH Policy on Dissemination of NIH-Funded Clinical Trial Information
|
| gptkbp:issuedBy |
gptkb:National_Institutes_of_Health
|
| gptkbp:nonComplianceMayResultIn |
suspension or termination of funding
|
| gptkbp:policyNumber |
NOT-OD-16-149
|
| gptkbp:publishedIn |
gptkb:NIH_Guide_for_Grants_and_Contracts
|
| gptkbp:relatedTo |
FDAAA 801 (Food and Drug Administration Amendments Act)
|
| gptkbp:requires |
results information submission to ClinicalTrials.gov
registration of clinical trials in ClinicalTrials.gov |
| gptkbp:startDate |
January 18, 2017
|
| gptkbp:bfsParent |
gptkb:FDAAA_801
|
| gptkbp:bfsLayer |
6
|